Project Code
PHS27Ex Fornwagner
Project Type
Dry lab
Research Theme
Population Health Science
Project Summary Download
Summary
Ozempic and Mounjaro (semaglutide and tirzepatide)—GLP-1 receptor agonists originally developed for diabetes—are now increasingly used for weight loss, with millions of people prescribed these medications. Yet we know almost nothing about how they affect economic and social decisions. Because these drugs act on the brain’s reward system, they may quietly change how patient, risk-taking, cooperative or competitive people are—with consequences for work, money and society. This PhD combines economics, psychology and health science to look into this topic for the first time. You will gain skills in behavioural experiments, data science and health research through meta-analysis, online experiments, and more.
Can the project be completed part time?
Yes
Lead Supervisor
Dr Helena Fornwagner
Lead Supervisor Email
University Affiliation
University of Exeter
